{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:10:28Z","timestamp":1794215428415,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013232","name":"Stiftelsen Norsk Luftambulanse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013232","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Danish HEMS Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Scand J Trauma Resusc Emerg Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Rapid identification and treatment of stroke is crucial for the outcome of the patient. We aimed to determine the performance of glial fibrillary acidic protein (GFAP) independently and in combination with the Prehospital Stroke Score (PreSS) for identification and differentiation of acute stroke within 4.5\u00a0h after symptom onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>Clinical data and serum samples were collected from the Treat-Norwegian Acute Stroke Prehospital Project (Treat-NASPP). Patients with suspected stroke and symptoms lasting\u2009\u2264\u20094.5\u00a0h had blood samples collected and were evaluated with the National Institutes of Health Stroke Scale prospectively. In this sub study, NIHSS was retrospectively translated into PreSS and GFAP was measured using the sensitive single molecule array (SIMOA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 299 patients with suspected stroke were recruited from Treat-NASPP and included in this study (44% acute ischemic stroke (AIS), 10% intracranial hemorrhage (ICrH), 7% transient ischemic attack (TIA), and 38% stroke mimics). ICrH was identified with a cross-fold validated area under the receiver-operating characteristic curve (AUC) of 0.73 (95% CI 0.62\u20130.84). A decision tree with PreSS and GFAP combined, first identified patients with a low probability of stroke. Subsequently, GFAP detected patients with ICrH with a 25.0% sensitivity (95% CI 11.5\u201343.4) and 100.0% specificity (95% CI 98.6\u2013100.0). Lastly, patients with large-vessel occlusion (LVO) were detected with a 55.6% sensitivity (95% CI 35.3\u201374.5) and 82.4% specificity (95% CI 77.3\u201386.7).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In unselected patients with suspected stroke, GFAP alone identified ICrH. Combined in a decision tree, GFAP and PreSS identified subgroups with high proportions of stroke mimics, ICrH, LVO, and AIS (non-LVO strokes).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13049-022-01065-7","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T04:03:49Z","timestamp":1672891429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Diagnostic performance of Glial Fibrillary Acidic Protein and Prehospital Stroke Scale for identification of stroke and stroke subtypes in an unselected patient cohort with symptom onset\u2009&lt;\u20094.5\u00a0h"],"prefix":"10.1186","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1697-745X","authenticated-orcid":false,"given":"Henriette S.","family":"J\u00e6ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8640-2355","authenticated-orcid":false,"given":"Ditte","family":"Tranberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-4231","authenticated-orcid":false,"given":"Karianne","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-7179","authenticated-orcid":false,"given":"Jan B.","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4846-9516","authenticated-orcid":false,"given":"Rolf A.","family":"Blauenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9236-2196","authenticated-orcid":false,"given":"Sebastian","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9167-1990","authenticated-orcid":false,"given":"Kristi G.","family":"Bache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2888-1842","authenticated-orcid":false,"given":"Martin F.","family":"Gude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"1065_CR1","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/CCM.0000000000004597","volume":"48","author":"F Herpich","year":"2020","unstructured":"Herpich F, Rincon F. Management of acute ischemic stroke. Crit Care Med. 2020;48:1654\u201363.","journal-title":"Crit Care Med"},{"key":"1065_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/CIRCULATIONAHA.116.023336","volume":"135","author":"JT Kim","year":"2017","unstructured":"Kim JT, Fonarow GC, Smith EE, et al. Treatment With tissue plasminogen activator in the golden hour and the shape of the 4.5-hour time-benefit curve in the National United States get with the guidelines-stroke population. Circulation. 2017;135:128\u201339.","journal-title":"Circulation"},{"key":"1065_CR3","doi-asserted-by":"publisher","first-page":"XLVIII","DOI":"10.1177\/23969873211012133","volume":"6","author":"EC Sandset","year":"2021","unstructured":"Sandset EC, Anderson CS, Bath PM, et al. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. Eur Stroke J. 2021;6:XLVIII\u2013LXXXIX.","journal-title":"Eur Stroke J"},{"key":"1065_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","volume":"372","author":"OA Berkhemer","year":"2015","unstructured":"Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11\u201320.","journal-title":"N Engl J Med"},{"key":"1065_CR5","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. The Lancet. 2016;387:1723\u201331.","journal-title":"The Lancet"},{"key":"1065_CR6","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581\u20138.","journal-title":"N Engl J Med"},{"key":"1065_CR7","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50:e344\u2013418.","journal-title":"Stroke"},{"key":"1065_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1747493019869830","volume":"15","author":"A Behrndtz","year":"2020","unstructured":"Behrndtz A, Johnsen SP, Valentin JB, et al. TRIAGE-STROKE: treatment strategy in acute larGE vessel occlusion: prioritize IV or endovascular treatment\u2014a randomized trial. Int J Stroke: Off J Int Stroke Soc. 2020;15:103\u20138.","journal-title":"Int J Stroke: Off J Int Stroke Soc"},{"key":"1065_CR9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/1747493019852176","volume":"14","author":"S Abilleira","year":"2019","unstructured":"Abilleira S, Perez de la Ossa N, Jimenez X, et al. Transfer to the local stroke center versus direct transfer to endovascular center of acute stroke patients with suspected large vessel occlusion in the Catalan territory (RACECAT): study protocol of a cluster randomized within a cohort trial. Int J Stroke: Off J Int Stroke Soc. 2019;14:734\u201344.","journal-title":"Int J Stroke: Off J Int Stroke Soc"},{"key":"1065_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/STROKEAHA.118.024091","volume":"50","author":"E Venema","year":"2019","unstructured":"Venema E, Groot AE, Lingsma HF, et al. Effect of interhospital transfer on endovascular treatment for acute ischemic stroke. Stroke. 2019;50:923\u201330.","journal-title":"Stroke"},{"key":"1065_CR11","first-page":"Cd011427","volume":"4","author":"Z Zhelev","year":"2019","unstructured":"Zhelev Z, Walker G, Henschke N, Fridhandler J, Yip S. Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack. Cochrane Database Syst Rev. 2019;4:Cd011427.","journal-title":"Cochrane Database Syst Rev"},{"key":"1065_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1474-4422(20)30439-7","volume":"20","author":"MHC Duvekot","year":"2021","unstructured":"Duvekot MHC, Venema E, Rozeman AD, et al. Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study. Lancet Neurol. 2021;20:213\u201321.","journal-title":"Lancet Neurol"},{"key":"1065_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jamaneurol.2020.4418","volume":"78","author":"TTM Nguyen","year":"2021","unstructured":"Nguyen TTM, van den Wijngaard IR, Bosch J, et al. Comparison of prehospital scales for predicting large anterior vessel occlusion in the ambulance setting. JAMA Neurol. 2021;78:157\u201364.","journal-title":"JAMA Neurol"},{"key":"1065_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13580","author":"MF Gude","year":"2022","unstructured":"Gude MF, Blauenfeldt RA, Behrndtz AB, et al. The Prehospital Stroke Score and telephone conference: a prospective validation. Acta Neurol Scand. 2022. https:\/\/doi.org\/10.1111\/ane.13580.","journal-title":"Acta Neurol Scand"},{"key":"1065_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0165-5728(85)80063-1","volume":"8","author":"LF Eng","year":"1985","unstructured":"Eng LF. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol. 1985;8:203\u201314.","journal-title":"J Neuroimmunol"},{"key":"1065_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s12975-010-0040-6","volume":"1","author":"R Brunkhorst","year":"2010","unstructured":"Brunkhorst R, Pfeilschifter W, Foerch C. Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings. Transl Stroke Res. 2010;1:246\u201351.","journal-title":"Transl Stroke Res"},{"key":"1065_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000172632","volume":"27","author":"F Dvorak","year":"2009","unstructured":"Dvorak F, Haberer I, Sitzer M, Foerch C. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc Dis. 2009;27:37\u201341.","journal-title":"Cerebrovasc Dis"},{"key":"1065_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1373\/clinchem.2011.172676","volume":"58","author":"C Foerch","year":"2012","unstructured":"Foerch C, Niessner M, Back T, et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem. 2012;58:237\u201345.","journal-title":"Clin Chem"},{"key":"1065_CR19","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1161\/STROKEAHA.117.018409","volume":"48","author":"AH Katsanos","year":"2017","unstructured":"Katsanos AH, Makris K, Stefani D, et al. Plasma glial fibrillary acidic protein in the differential diagnosis of intracerebral hemorrhage. Stroke. 2017;48:2586\u20138.","journal-title":"Stroke"},{"key":"1065_CR20","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s10072-015-2317-8","volume":"36","author":"L Xiong","year":"2015","unstructured":"Xiong L, Yang Y, Zhang M, Xu W. The use of serum glial fibrillary acidic protein test as a promising tool for intracerebral hemorrhage diagnosis in Chinese patients and prediction of the short-term functional outcomes. Neurol Sci. 2015;36:2081\u20137.","journal-title":"Neurol Sci"},{"key":"1065_CR21","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1468-1331.2006.01435.x","volume":"13","author":"MT Wunderlich","year":"2006","unstructured":"Wunderlich MT, Wallesch CW, Goertler M. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol. 2006;13:1118\u201323.","journal-title":"Eur J Neurol"},{"key":"1065_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000453460","volume":"43","author":"M Rozanski","year":"2017","unstructured":"Rozanski M, Waldschmidt C, Kunz A, et al. Glial fibrillary acidic protein for prehospital diagnosis of intracerebral hemorrhage. Cerebrovasc Dis. 2017;43:76\u201381.","journal-title":"Cerebrovasc Dis"},{"key":"1065_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1373\/clinchem.2016.263335","volume":"63","author":"S Luger","year":"2017","unstructured":"Luger S, Witsch J, Dietz A, et al. Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke. Clin Chem. 2017;63:377\u201385.","journal-title":"Clin Chem"},{"key":"1065_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1208\/s12248-014-9682-8","volume":"17","author":"SK Fischer","year":"2015","unstructured":"Fischer SK, Joyce A, Spengler M, et al. Emerging technologies to increase ligand binding assay sensitivity. AAPS J. 2015;17:93\u2013101.","journal-title":"AAPS J"},{"key":"1065_CR25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011742","author":"A Bustamante","year":"2021","unstructured":"Bustamante A, Penalba A, Orset C, et al. Blood biomarkers to differentiate ischemic and hemorrhagic strokes might allow prehospital thrombolysis. Neurology. 2021. https:\/\/doi.org\/10.1212\/WNL.0000000000011742.","journal-title":"Neurology"},{"key":"1065_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3390\/diagnostics11071137","volume":"11","author":"E Gaude","year":"2021","unstructured":"Gaude E, Nogueira B, Ladreda Mochales M, et al. A novel combination of blood biomarkers and clinical stroke scales facilitates detection of large vessel occlusion ischemic strokes. Diagnostics (Basel). 2021;11:1137.","journal-title":"Diagnostics (Basel)"},{"key":"1065_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14877","author":"K Larsen","year":"2021","unstructured":"Larsen K, Jaeger HS, Tveit LH, et al. Ultraearly thrombolysis by an anesthesiologist in a mobile stroke unit a prospective, controlled intervention study. Eur J Neurol. 2021. https:\/\/doi.org\/10.1111\/ene.14877.","journal-title":"Eur J Neurol"},{"key":"1065_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.036084","author":"K Larsen","year":"2022","unstructured":"Larsen K, J\u00e6ger HS, Hov MR, et al. Streamlining acute stroke care by introducing National Institutes of Health Stroke Scale in the emergency medical services: a prospective cohort study. Stroke. 2022. https:\/\/doi.org\/10.1161\/STROKEAHA.121.036084.","journal-title":"Stroke"},{"key":"1065_CR29","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44:2064\u201389.","journal-title":"Stroke"},{"key":"1065_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/0141076816680121","volume":"110","author":"AP Coupland","year":"2017","unstructured":"Coupland AP, Thapar A, Qureshi MI, Jenkins H, Davies AH. The definition of stroke. J R Soc Med. 2017;110:9\u201312.","journal-title":"J R Soc Med"},{"key":"1065_CR31","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/neuros\/nyz042","volume":"85","author":"RC Rennert","year":"2019","unstructured":"Rennert RC, Wali AR, Steinberg JA, et al. Epidemiology, natural history, and clinical presentation of large vessel ischemic stroke. Neurosurgery. 2019;85:S4\u20138.","journal-title":"Neurosurgery"},{"key":"1065_CR32","unstructured":"Organization WH. International statistical classification of disease and related problems 10th revision [online]. https:\/\/icd.who.int\/browse10\/2010\/en."},{"key":"1065_CR33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1515\/cclm-2022-0007","volume":"60","author":"Z van Lierop","year":"2022","unstructured":"van Lierop Z, Verberk IMW, van Uffelen KWJ, et al. Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1. Clin Chem Lab Med. 2022;60:842\u201350.","journal-title":"Clin Chem Lab Med"},{"key":"1065_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/2211068215589580","volume":"21","author":"DH Wilson","year":"2015","unstructured":"Wilson DH, Rissin DM, Kan CW, et al. The Simoa HD-1 analyzer: a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing. J Lab Autom. 2015;21:533\u201347.","journal-title":"J Lab Autom"},{"key":"1065_CR35","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.011","volume":"27","author":"KW Faiz","year":"2018","unstructured":"Faiz KW, Labberton AS, Thommessen B, R\u00f8nning OM, Dahl FA, Barra M. The burden of stroke mimics: present and future projections. J Stroke Cerebrovasc Dis. 2018;27:1288\u201395.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1065_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000453460","volume":"43","author":"M Rozanski","year":"2017","unstructured":"Rozanski M. Glial fibrillary acidic protein for prehospital diagnosis of intracerebral hemorrhage. Cerebrovasc Dis (Basel, Switz). 2017;43:76\u201381.","journal-title":"Cerebrovasc Dis (Basel, Switz)"},{"key":"1065_CR37","doi-asserted-by":"publisher","first-page":"24588","DOI":"10.1038\/srep24588","volume":"6","author":"C Ren","year":"2016","unstructured":"Ren C. Assessment of serum UCH-L1 and GFAP in acute stroke patients. Sci Rep. 2016;6:24588.","journal-title":"Sci Rep"},{"key":"1065_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00415-009-0054-8","volume":"256","author":"J Und\u00e9n","year":"2009","unstructured":"Und\u00e9n J. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation. J Neurol. 2009;256:72\u20137.","journal-title":"J Neurol"},{"key":"1065_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12028-020-00931-5","volume":"33","author":"S Luger","year":"2020","unstructured":"Luger S, J\u00e6ger HS, Dixon J, et al. Diagnostic accuracy of glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase-L1 serum concentrations for differentiating acute intracerebral hemorrhage from ischemic stroke. Neurocrit Care. 2020;33:39\u201348.","journal-title":"Neurocrit Care"},{"key":"1065_CR40","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/clinchem\/hvab128","volume":"67","author":"OS Mattila","year":"2021","unstructured":"Mattila OS, Ashton NJ, Blennow K, et al. Ultra-early differential diagnosis of acute cerebral ischemia and hemorrhagic stroke by measuring the prehospital release rate of GFAP. Clin Chem. 2021;67:1361\u201372.","journal-title":"Clin Chem"},{"key":"1065_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1354750X.2019.1691657","volume":"25","author":"A Kumar","year":"2020","unstructured":"Kumar A, Misra S, Yadav AK, et al. Role of glial fibrillary acidic protein as a biomarker in differentiating intracerebral haemorrhage from ischaemic stroke and stroke mimics: a meta-analysis. Biomarkers. 2020;25:1\u20138.","journal-title":"Biomarkers"},{"key":"1065_CR42","unstructured":"Fj\u00e6rtoft H, Skogseth-Stephani R, Indredavik B, Krokan TG, Bjerkvik TF, Halle KK, Varmdal V. \u00c5rsrapport for 2021. 2022. https:\/\/www.kvalitetsregistre.no\/register\/hjerte-og-karsykdommer\/norsk-hjerneslagregister. Norsk Hjerneslagregister."}],"container-title":["Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-022-01065-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13049-022-01065-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-022-01065-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T20:03:23Z","timestamp":1673208203000},"score":1,"resource":{"primary":{"URL":"https:\/\/sjtrem.biomedcentral.com\/articles\/10.1186\/s13049-022-01065-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1186\/s13049-022-01065-7","relation":{},"ISSN":["1757-7241"],"issn-type":[{"value":"1757-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,5]]},"assertion":[{"value":"2 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Regional Committees for Medical and Health Research Ethics approved the Treat-NASPP (document-ID: 2016\/974) and the Biomarker Study (document-id: 2014\/1161). Guarantor: MFG.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained from all subjects or legal representative in the acute\nphase, during hospital stay, or after discharge.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no potentially conflicting interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}